View Post

New compounds offer a two-for-one punch to fight estrogen-sensitive breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Scripps Research Institute From: A set of compounds developed by scientists at Scripps Research in Florida target estrogen-sensitive breast cancer cells in new ways, potentially creating better options for patients with treatment-resistant cancers. “Hormone therapies for breast cancer have been one of the greatest success stories of molecularly targeted medicines. But a significant fraction of patients don’t respond …